FENC: Hackman Jeffrey S. discloses securities transactions
By AlphaYouPublished Form 4
Hackman Jeffrey S.
Reporting filer
Hackman Jeffrey S. reported Grant or award in FENNEC PHARMACEUTICALS INC.: 1159 units of Common Shares, dated 2026-09-30. The full Form 4 contains 1 transaction entry.
- Disclosed
- Oct 1, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Hackman Jeffrey S. | 2026-09-30 | A | Grant or award | 1159 | 0 | 67,461 | 1 day | Filed terms
|
Common Shares
- Owner
- Hackman Jeffrey S.
- Date
- 2026-09-30
- Code
- A
- Action
- Grant or award
- Quantity
- 1159
- Price
- 0
- Following holdings
- 67,461
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Common Shares
- id: F1
- transaction Date: 2026-09-30
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Shares: 1159
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 67461
- direct Or Indirect Ownership: D
- nature Of Ownership:
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Hackman Jeffrey S.: Chief Executive Officer, Director.
- F1: Represents shares released from restriction from shares awarded 3/28/2025.
Original sources
Prepared automatically from public filing data. Report a correction.